U.S. flag

An official website of the United States government

GTR Home > Tests > Dyslipidemia NGS panel (29 genes), Sequence & CNV analysis

Overview

Test name

Help

Dyslipidemia NGS panel (29 genes), Sequence & CNV analysis

Purpose of the test

Help

This is a clinical test intended for Help: Diagnosis, Drug Response

Condition

Help

Click Indication tab for more information.

How to order

Help

Using our website
Order URL Help: https://genomediagnostics.amsterdamumc.nl/information-and-order/catalog/home.html?q=Dyslipidemia

Specimen source

Isolated DNA
Peripheral (whole) blood

Methodology

Help
Molecular Genetics
DDeletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina MiSeq
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina MiSeq

Summary of what is tested

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Testing strategy

Help

Next Generation Sequencing of 29 genes. Low-coverage regions (<30 reads) are analysed by Sanger Sequencing. CNV analysis is performed on NGS data. 000 Using our website

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.